Showing 1 - 5 results of 5 for search 'Wenge Xing', query time: 0.02s
Refine Results
-
1
3D CNT/MXene microspheres for combined photothermal/photodynamic/chemo for cancer treatment by Wei Gao, Wei Gao, Wei Gao, Wei Gao, Weihao Zhang, Weihao Zhang, Weihao Zhang, Haipeng Yu, Haipeng Yu, Haipeng Yu, Wenge Xing, Wenge Xing, Wenge Xing, Xueling Yang, Xueling Yang, Xueling Yang, Yongguang Zhang, Chunyong Liang
Published 2022-09-01
Article -
2
Hepatic arterial infusion chemotherapy in hepatocellular carcinoma: A bibliometric and knowledge-map analysis by Mei Li, Mei Li, Mei Li, Kai Zhang, Kai Zhang, Kai Zhang, Ji’an He, Ji’an He, Ji’an He, Weihao Zhang, Weihao Zhang, Weihao Zhang, Tianye Lv, Tianye Lv, Tianye Lv, Li Wang, Li Wang, Li Wang, Wenge Xing, Wenge Xing, Wenge Xing, Haipeng Yu, Haipeng Yu, Haipeng Yu
Published 2023-01-01
Article -
3
-
4
A preliminary study of optimal treatment response rates in patients undergoing hepatic arterial infusion chemotherapy combined with molecular targeting and immunotherapy by Mei Li, Mei Li, Mei Li, Jun Liao, Jun Liao, Jun Liao, Li Wang, Li Wang, Li Wang, Tianye Lv, Tianye Lv, Tianye Lv, Qianfu Sun, Qianfu Sun, Qianfu Sun, Yan Xu, Yan Xu, Yan Xu, Zhi Guo, Zhi Guo, Zhi Guo, Manman Quan, Manman Quan, Manman Quan, Hao Qin, Hao Qin, Hao Qin, Haoyang Yu, Kai Zhang, Kai Zhang, Wenge Xing, Wenge Xing, Wenge Xing, Haipeng Yu, Haipeng Yu, Haipeng Yu
Published 2024-04-01
Article -
5
Hepatic arterial infusion chemotherapy combined with anti-PD-1/PD-L1 immunotherapy and molecularly targeted agents for advanced hepatocellular carcinoma: a real world study by Weihao Zhang, Weihao Zhang, Weihao Zhang, Kai Zhang, Kai Zhang, Kai Zhang, Changfu Liu, Changfu Liu, Changfu Liu, Wei Gao, Wei Gao, Wei Gao, Tongguo Si, Tongguo Si, Tongguo Si, Qiang Zou, Qiang Zou, Qiang Zou, Zhi Guo, Zhi Guo, Zhi Guo, Xueling Yang, Xueling Yang, Xueling Yang, Mei Li, Mei Li, Mei Li, Dongming Liu, Dongming Liu, Dongming Liu, Han Mu, Han Mu, Han Mu, Huikai Li, Huikai Li, Huikai Li, Haipeng Yu, Haipeng Yu, Haipeng Yu, Wenge Xing, Wenge Xing, Wenge Xing
Published 2023-04-01
Article